当前位置：
X-MOL 学术
›
Allergy Asthma Clin. Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy.
Allergy, Asthma & Clinical Immunology ( IF 2.7 ) Pub Date : 2020-05-20 , DOI: 10.1186/s13223-020-00435-z Alexandra Langlois 1 , Marie-Hélène Lavergne 2 , Hélène Leroux 2 , Kerstin Killer 2 , Pauline Azzano 1 , Louis Paradis 1, 3 , Kathryn Samaan 1 , Jonathan Lacombe-Barrios 1 , Thomas Eiwegger 4 , Julia Upton 4 , Gordon Sussman 5 , Thomas Poder 6, 7 , Benoît Mâsse 2, 8 , Anne Des Roches 1, 2 , Philippe Bégin 1, 2, 3
Allergy, Asthma & Clinical Immunology ( IF 2.7 ) Pub Date : 2020-05-20 , DOI: 10.1186/s13223-020-00435-z Alexandra Langlois 1 , Marie-Hélène Lavergne 2 , Hélène Leroux 2 , Kerstin Killer 2 , Pauline Azzano 1 , Louis Paradis 1, 3 , Kathryn Samaan 1 , Jonathan Lacombe-Barrios 1 , Thomas Eiwegger 4 , Julia Upton 4 , Gordon Sussman 5 , Thomas Poder 6, 7 , Benoît Mâsse 2, 8 , Anne Des Roches 1, 2 , Philippe Bégin 1, 2, 3
Affiliation
An amendment to this paper has been published and can be accessed via the original article.
中文翻译：
更正：关于奥马珠单抗在多食物口服免疫疗法中剂量相关疗效的双盲、随机对照试验方案。
本文的修订版已发布，可通过原始文章访问。
更新日期：2020-05-20
中文翻译：
更正：关于奥马珠单抗在多食物口服免疫疗法中剂量相关疗效的双盲、随机对照试验方案。
本文的修订版已发布，可通过原始文章访问。
京公网安备 11010802027423号